E

Elanco

Global animal health pharmaceutical company

Target Intelligence & Discovery Lead

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeIndianapolis, IN, USANo salary listedIn-person

About the Job

Requirements

  • A PhD in Molecular Biology, Biochemistry, Pharmacology, or a related scientific discipline is required.
  • At least 10 years of discovery research experience in the pharmaceutical or animal health industry, focused on target identification and validation.
  • Demonstrated people leadership experience and a track record of building and managing high-performing scientific teams.
  • Strong background in AI/ML predictive modeling, 3D cell systems such as organoids, and intellectual property strategy for biological targets.
  • Ability to drive an innovation engine by securing proprietary breakthroughs rather than adapting existing science.

Responsibilities

  • Manage and develop a high-performing team of discovery scientists.
  • Foster scientific excellence, intellectual curiosity, and rigorous checks and balances within the discovery engine.
  • Provide mentorship and strategic oversight to align the team’s research outputs with Elanco’s long-term growth objectives.
  • Lead the function for gathering and synthesizing emerging target selection and validation data.
  • Drive identification of first-in-class targets in innovation white space.
  • Serve as the primary partner to AI/ML teams, using predictive modeling for target, disease, toxicology, and safety assessments.
  • Oversee development and implementation of organoid and 3D cell models to improve target translation and predictive accuracy.
  • Continuously evaluate and institutionalize emerging target selection and validation methodologies.
  • Lead the target validation process, including assessment of BioA needs and partnership on foundational intellectual property.
  • Direct rigorous biological assessments to verify target relevance and mechanism of action.
  • Ensure that only scientifically sound, high-integrity targets advance through the pipeline.
  • Oversee formal Target Assessments to de-risk early-stage programs before progression.
  • Lead projects at the beginning of the pipeline through target validation.
  • Define the discovery approach and modality plan at CP0 for every program in the portfolio.
  • Drive identification and early validation of biomarkers and biosignals to enable clinical translation.
  • Partner with RBI Integration and Performance to align discovery outputs with the broader portfolio.

About the Company

Elanco

Global animal health pharmaceutical company

Elanco is a global animal health company that develops and sells medicines, vaccines, and preventive care products for livestock and pets. Its portfolio includes prescription medicines, vaccines, parasite controls, and other welfare products used by veterinarians, farmers, and pet owners to prevent or treat disease and improve wellbeing. Since becoming independent after separating from Eli Lilly and acquiring Bayer Animal Health in 2020, it ranks as the world’s second-largest animal health company with a broad, globally distributed product line and direct-to-consumer capabilities. Its goal is to improve animal health and welfare worldwide by providing effective, accessible products and services while growing sustainably.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Indianapolis, IN
Founded
1954

Recently Posted Jobs

Explore more opportunities at Elanco

See more jobs